1qwh
From Proteopedia
| Line 1: | Line 1: | ||
[[Image:1qwh.gif|left|200px]] | [[Image:1qwh.gif|left|200px]] | ||
| - | + | <!-- | |
| - | + | The line below this paragraph, containing "STRUCTURE_1qwh", creates the "Structure Box" on the page. | |
| - | + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | |
| - | | | + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), |
| - | | | + | or leave the SCENE parameter empty for the default display. |
| - | + | --> | |
| - | + | {{STRUCTURE_1qwh| PDB=1qwh | SCENE= }} | |
| - | + | ||
| - | + | ||
| - | }} | + | |
'''a covalent dimer of transthyretin that affects the amyloid pathway''' | '''a covalent dimer of transthyretin that affects the amyloid pathway''' | ||
| Line 28: | Line 25: | ||
[[Category: Kelker, M S.]] | [[Category: Kelker, M S.]] | ||
[[Category: Wilson, I A.]] | [[Category: Wilson, I A.]] | ||
| - | [[Category: | + | [[Category: Binding protein]] |
| - | [[Category: | + | [[Category: Cerebrospinal fluid]] |
| - | [[Category: | + | [[Category: Disease mutation]] |
| - | [[Category: | + | [[Category: Liver]] |
| - | [[Category: | + | [[Category: Plasma]] |
| - | [[Category: | + | [[Category: Polymorphism]] |
| - | [[Category: | + | [[Category: Polyneuropathy]] |
| - | [[Category: | + | [[Category: Signal]] |
| - | [[Category: | + | [[Category: Thyroid hormone]] |
| - | [[Category: | + | [[Category: Thyroxine]] |
| - | [[Category: | + | [[Category: Transport]] |
| - | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 06:46:53 2008'' | |
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | |
Revision as of 03:46, 3 May 2008
a covalent dimer of transthyretin that affects the amyloid pathway
Overview
The amyloidogenic homotetrameric protein transthyretin (TTR) must undergo rate-limiting dissociation to partially denatured monomers in order to aggregate. TTR contains two distinct quaternary interfaces, one of which defines the binding sites for thyroxine and small-molecule amyloidogenesis inhibitors. Kinetic stabilization of the tetramer can be accomplished either by the binding of amyloidogenesis inhibitors selectively to the native state over the dissociative transition state or by the introduction of trans-suppressor subunits (T119M) into heterotetramers to destabilize the dissociative transition state. In each case, increasing the dissociation activation barrier prevents tetramer dissociation. Herein, we demonstrate that tethering two subunits whose quaternary interface defines the thyroxine binding site also dramatically increases the barrier for tetramer dissociation, apparently by destabilization of the dissociative transition state. The tethered construct (TTR-L-TTR)2 is structurally and functionally equivalent to wild-type TTR. Urea is unable to denature (TTR-L-TTR)2, yet it is able to maintain the denatured state once denaturation is achieved by GdnHCl treatment, suggesting that (TTR-L-TTR)2 is kinetically rather than thermodynamically stabilized, consistent with the identical wild-type TTR and (TTR-L-TTR)2 GdnHCl denaturation curves. Studies focused on a construct containing a single TTR-L-TTR chain and two normal monomer subunits establish that alteration of only one quaternary structural interface is sufficient to impose kinetic stabilization on the entire quaternary structure.
About this Structure
1QWH is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
Kinetic stabilization of the native state by protein engineering: implications for inhibition of transthyretin amyloidogenesis., Foss TR, Kelker MS, Wiseman RL, Wilson IA, Kelly JW, J Mol Biol. 2005 Apr 8;347(4):841-54. PMID:15769474 Page seeded by OCA on Sat May 3 06:46:53 2008
